OncoCyte Corp Change of Control Agreements
4 Contracts & Agreements
- Amended & Restated Change in Control and Executive Severance Plan Agreement, by and between the Company and Joshua Riggs, effective as of December 2, 2022 (Filed With SEC on December 5, 2022)
- Change in Control and Executive Severance Plan Agreement, dated October 4 2021, between Oncocyte Corporation and Gisela Paulsen (Filed With SEC on October 7, 2021)
- Form of Change in Control and Severance Agreement (Filed With SEC on March 26, 2020)
- Oncocyte Corporation Change in Control and Severance Plan (Filed With SEC on March 26, 2020)
